| Code | 2122C | ||||||||||
| MA number | 73/0516/16-S | ||||||||||
| Product Form: | tbl flm 100x10 mg (blis.Al/OPA/Al/PVC) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Farmak International Sp. z o.o., Poland | ||||||||||
| Therapeutic Class: | 73 - SPASMOLYTICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | blister Al/OPA/Al/PVC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 13.12.2016 |
| PIL: |
PIL_Solixa_tbl flm_08_2023.pdf
|
| SPC: |
SPC_Solixa_tbl flm_08_2023.pdf
|
| Safety feature | Yes |
| Data update: | 27.10.2021 |
